Vergleich

SH2D1A Blocking Peptide (C-term)

ArtNr ABC-BP19972b
Hersteller Abcepta
Menge 500 ug
Kategorie
Typ Peptides
Format Lyophilized
Specific against other
Citations Ameratunga, R., et al. N. Z. Med. J. 122(1304):46-53(2009)
Snow, A.L., et al. J. Clin. Invest. 119(10):2976-2989(2009)
Nagy, N., et al. Proc. Natl. Acad. Sci. U.S.A. 106(29):11966-11971(2009)
Ostrakhovitch, E.A., et al. Cell. Signal. 21(4):540-550(2009)
Schwartzberg, P.L., et al. Nat. Rev. Immunol. 9(1):39-46(2009)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias SH2 domain-containing protein 1A,Duncan disease SH2-protein,Signaling lymphocytic activation molecule-associated protein,SLAM-associated protein,T-cell signal transduction molecule SAP,SH2D1A,DSHP,SAP
Similar products SH2D1A, DSHP, SAP, SH2 domain-containing protein 1A, Duncan disease SH2-protein, Signaling lymphocytic activation molecule-associated protein, T-cell signal transduction molecule SAP, SLAM-associated protein
Lieferbar
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence is selected from aa 100-114 of HUMAN SH2D1A
Bio Background
This gene encodes a protein that plays a major role in thebidirectional stimulation of T and B cells. This protein containsan SH2 domain and a short tail. It associates with the signalinglymphocyte-activation molecule, thereby acting as an inhibitor ofthis transmembrane protein by blocking the recruitment of theSH2-domain-containing signal-transduction molecule SHP-2 to itsdocking site. This protein can also bind to other related surfacemolecules that are expressed on activated T, B and NK cells, thereby modifying signal transduction pathways in these cells.Mutations in this gene cause lymphoproliferative syndrome X-linkedtype 1 or Duncan disease, a rare immunodeficiency characterized byextreme susceptibility to infection with Epstein-Barr virus, withsymptoms including severe mononucleosis and malignant lymphoma.Multiple transcript variants encoding different isoforms have beenfound for this gene.
Gene Name
SH2D1A
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 500 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen